Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Ascendis Pharma A/S
ASND
$16.8B
| $379M | 0.25% |
3,532,830
-111,125
| -3% | -$12.7M |
|
102
Walt Disney
DIS
$181B
| $378M | 0.25% |
3,773,376
+95,503
| +3% | +$9.63M |
|
103
Hershey
HSY
$36.6B
| $371M | 0.24% |
1,456,372
+14,928
| +1% | +$3.51M |
|
104
Sysco
SYY
$40.3B
| $361M | 0.24% |
4,668,479
+689,567
| +17% | +$52.9M |
|
105
Costco
COST
$420B
| $356M | 0.23% |
716,270
-6,551
| -0.9% | -$3.21M |
|
106
Synopsys
SNPS
$79.7B
| $351M | 0.23% |
908,133
-12,558
| -1% | -$4.49M |
|
107
Cooper Companies
COO
$14.5B
| $350M | 0.23% |
3,754,656
-419,204
| -10% | -$36M |
|
108
Edwards Lifesciences
EW
$51.7B
| $348M | 0.23% |
4,201,195
+374,517
| +10% | +$29.4M |
|
109
Cisco
CSCO
$479B
| $342M | 0.23% |
6,535,704
+1,485,537
| +29% | +$72.5M |
|
110
TFI International
TFII
$11.5B
| $341M | 0.22% |
2,854,710
+1,399,515
| +96% | +$163M |
|
111
ServiceNow
NOW
$129B
| $334M | 0.22% |
3,597,695
-94,485
| -3% | -$8.23M |
|
112
BioMarin Pharmaceuticals
BMRN
$12.4B
| $334M | 0.22% |
3,437,284
-451,160
| -12% | -$46.8M |
|
113
Novartis
NVS
$297B
| $332M | 0.22% |
3,610,783
-322,510
| -8% | -$28.2M |
|
114
Zoetis
ZTS
$30B
| $331M | 0.22% |
1,990,089
+202,748
| +11% | +$33.2M |
|
115
Goldman Sachs
GS
$303B
| $325M | 0.21% |
994,393
+66,355
| +7% | +$23.1M |
|
116
Prologis
PLD
$133B
| $319M | 0.21% |
2,559,549
+63,209
| +3% | +$7.77M |
|
117
O'Reilly Automotive
ORLY
$76.3B
| $318M | 0.21% |
5,620,620
-365,235
| -6% | -$20M |
|
118
Aramark
ARMK
$14.7B
| $316M | 0.21% |
12,233,841
+138,489
| +1% | +$3.94M |
|
|
NATI
119
DELISTED
National Instruments Corp
NATI
| $313M | 0.21% |
5,973,988
-2,911,022
| -33% | -$146M |
|
|
APLS
120
DELISTED
Apellis Pharmaceuticals
APLS
| $309M | 0.2% |
4,681,482
+693,737
| +17% | +$40M |
|
121
Dentsply Sirona
XRAY
$2.43B
| $303M | 0.2% |
7,704,667
+526,339
| +7% | +$19.3M |
|
122
Ziff Davis
ZD
$1.98B
| $300M | 0.2% |
3,848,674
-35,086
| -0.9% | -$2.88M |
|
123
CarMax
KMX
$8.26B
| $292M | 0.19% |
4,540,382
-2,126
| -0% | -$142K |
|
124
Intuit
INTU
$89B
| $289M | 0.19% |
647,183
+287,218
| +80% | +$118M |
|
125
Automatic Data Processing
ADP
$108B
| $287M | 0.19% |
1,289,799
+744,403
| +136% | +$168M |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.